iTonic Holdings Ltd. (NASDAQ:ITOC) — Market Cap & Net Worth
Market Cap & Net Worth: iTonic Holdings Ltd. (ITOC)
iTonic Holdings Ltd. (NASDAQ:ITOC) has a market capitalization of $3.31 Million ($3.31 Million) as of May 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29060 globally and #5699 in its home market, demonstrating a 17.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying iTonic Holdings Ltd.'s stock price $0.35 by its total outstanding shares 9382000 (9.38 Million). Analyse cash flow conversion of iTonic Holdings Ltd. to see how efficiently the company converts income to cash.
iTonic Holdings Ltd. Market Cap History: 2026 to 2026
iTonic Holdings Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $3.31 Million to $3.31 Million (0.00% CAGR).
iTonic Holdings Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how iTonic Holdings Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ITOC by Market Capitalization
Companies near iTonic Holdings Ltd. in the global market cap rankings as of May 4, 2026.
Key companies related to iTonic Holdings Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
iTonic Holdings Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, iTonic Holdings Ltd.'s market cap moved from $3.31 Million to $ 3.31 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.31 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of iTonic Holdings Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.31 Million USD |
| MoneyControl | $3.31 Million USD |
| MarketWatch | $3.31 Million USD |
| marketcap.company | $3.31 Million USD |
| Reuters | $3.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About iTonic Holdings Ltd.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment p… Read more